Press Coverage

Cellvizio Technology Helps Detect Precancerous Cells

10 October 2018

Read the full article on "Dr. Stephen Matter M.D. in Normal, Illinois using a fairly new technology to detect and diagnose precancerous conditions in the esophagus. He treats patients with chronic heartburn, acid reflux and indigestion caused by stomach acid getting into the esophagus."

Latest News

Mauna Kea Technologies and Endotherapeutics Announce Cellvizio® First Australian Orders, Advancing CellTolerance® Commercial Expansion 

Mauna Kea Technologies and Endotherapeutics Announce Cellvizio® First Australian Orders, Advancing CellTolerance® Commercial Expansion 

Mauna Kea Technologies Unveils the Outlines of its Safeguard Plan to Ensure its Turnaround

Mauna Kea Technologies Unveils the Outlines of its Safeguard Plan to Ensure its Turnaround

Mauna Kea Technologies Announces Strong Advocacy from the American Foregut Society (AFS) for Broad Reimbursement Coverage from U.S. Commercial Payors for Cellvizio 

Mauna Kea Technologies Announces Strong Advocacy from the American Foregut Society (AFS) for Broad Reimbursement Coverage from U.S. Commercial Payors for Cellvizio 

No results found.